Treatment TNBC and ERBB2+ breast cancer cells with neratinib also reduced the expression of p62 SQMT1, LAMP2, HDAC6, DRP-1, mitochondrial HSP70, HSP70, HSP90 and GRP78 (Figure 7B and 7C). This evidence concerns the gene ERBB2 and breast cancer.